← SynDRA

MILTEFOSINE

SynDRA canonical compound SYN0001197 — structure-anchored drug synonym record

All known targets

• AKT1
• PLA2G1B
• CDC25A

Mechanisms of action (all sources)

• AKT1 INHIBITOR
• membrane integrity inhibitor
• PLA2G1B INHIBITOR

Drug classes

• Anti-Infective Agents
• Antifungal Agents
• Antineoplastic Agents
• Antiparasitic Agents
• Antiprotozoal Agents
• Antileishmanial

ATC classes

• P01C · AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS

Cross-references

• PubChem CID: 3599
• ChEMBL: CHEMBL125
• DrugBank: DB09031
• ChEBI: CHEBI:75283
• KEGG: D02494
• RxNorm: 1494066
• Wikipedia: Miltefosine
• TTD: D00FGR

Synonyms

• impavido
• hexadecylphosphocholine
• hexadecylphosphorylcholine
• miltefos
• Miltefosina
• D-18506
• NSC-605583
• NSC-758968
• Impavido
• Miltex
• HDPC
• HePC
• Hexadecylphosphocholine
• Hexadecylphosphorylcholine
• Miltefosinum
• Baxter Oncology brand of miltefosine
• Baxter brand of miltefosine
• Miltefosin C
• Prasfarma brand of miltefosine
• IN1227
• H-1850
• M-7200
• Miltefosina [INN-Spanish]
• Miltefosine (INN)
• Miltefosine[INN:BAN]
• Miltefosinum [INN-Latin]
• N-Hexadecylphosphorylcholine
• TF-002
• Choline hydroxide, hexadecyl hydrogen phosphate, inner salt
• Choline, hexadecyl hydrogen phosphate, inner salt
• Hexadecyl 2-(trimethylazaniumyl)ethyl phosphate
• Choline phosphate, hexadecyl ester, hydroxide, inner salt
• Choline phosphate, hexadecyl ester, hydroxide, inner salt (6CI)
• Hexadecyl 2-(trimethyl-.lambda.~5~-azanyl)ethyl hydrogen phosphate
• Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, inner salt
• Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, innner salt
• 1-Hexadecylphosphorylcholine
• 2-(((Hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethylethanaminium hydroxide, inner salt

Reported adverse events

• Asthenia
• Dizziness
• Headache
• Lymphangitis
• Malaise
• Nausea
• Pruritus
• Pyrexia
• Somnolence
• Stevens-Johnson syndrome
• Vomiting